2021 U.S. Generic and Biosimilar Medicines Savings Report

Sidelined: How Seniors Miss Out On Savings Available Through Generic Substitution

Access Denied: Why New Generics Are Not Reaching America’s Seniors

AAM Securing Sustainable Markets

Medicare and Commercial Plans Fail to Get New Generics to Patients
